13-15 febbraio 2013
Palazzo dei Congressi | Piazza Adua 1, 50123 Firenze
La fibrillazione atriale è una patologia complessa, che necessita di una mobilitazione concreta da parte delle Istituzioni e del Mondo Scientifico per analizzare e proporre soluzioni efficaci nella lotta a questa grave problematica
La malattia cerebrovascolare è uno dei maggiori problemi so- ciosanitari: è la seconda causa di morte e la prima causa di invalidità a livello mondiale. Ogni anno in Italia si contano 196.000 eventi cerebrova- scolari, di cui il 20% è una recidiva (39.000)
Obesity is steadily becoming the greatest health problem in the developed world. The prevalence of overweight and obesity has reached pandemic proportions worldwide. It has recently been estimated that 1.1 billion people are overfed and overweight (1). It causes impaired function of the large arteries, which might be the consequence of metabolic dysregulation, inflammatory pathways, obstructive sleep apnea, or other mechanisms
The commonly used measurement to assess carotid “atherosclerosis” is intima media thickness (IMT). Recently, however, newer measurements such as assessment of plaque area or total plaque volume (TPV) have been suggested to represent a potentially more powerful approach, since these measurements in higher dimensions evaluate plaque burden in the carotid system and hold great sensitivity and discrimination [6-8]. IMT and TPV, however, are not interchangeable
Cigarette smoking is a causative factor for premature atherosclerosis [1,2]. However, the exact mechanism of smoking-induced damage to the arterial wall and its relation to the atherosclerotic process is still largely obscure. The adverse effects of smoking on vascular wall structure has been historically evaluated by autopsy studies